Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Cystic Fibrosis: Pathogenesis
Chronic Pancreatitis II: Pathophysiology
Cystic Fibrosis: Management
Acute Pancreatitis II: Pathophysiology
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 24, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Jonas Rosendahl1, Olfert Landt, Jana Bernadova
1Department for Paediatrics & Else Kröner-Fresenius-Zentrum (EKFZ), Technical University Munich (TUM), Gregor-Mendel-Str. 2, 85350 Freising, Germany.
Genetic analysis reveals that while cystic fibrosis transmembrane conductance regulator (CFTR) variants increase chronic pancreatitis risk, compound and trans-heterozygosity are significant factors. However, the overall influence of CFTR alterations on CP development appears minor.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: